Ahencio, Belen A.
HRN: 26-18-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/16/2025
01/23/2025
IVTT
600 Mg
Q 6H
Infected Wound, Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes